Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Aug 2026 for Rocket Pharmaceuticals, INC., €111k. Read the official filing
Filing timeline
BuySaleChristopher James Stevens
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Christopher James Stevens: trading record in brief
All filings by Christopher James Stevens on record concern Rocket Pharmaceuticals, Inc. We count 4 filings; the first trade dates from 4 August 2025 and the latest from 11 August 2026.
Sales make up the whole of the open-market record (1 sale, €111k). Other entries cover 3 share grants. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 13 August 2026: an open-market sale of €111k, in Rocket Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher James Stevens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
36,658 shares@ US$3.4990.038% mcap50.0% of flowCommon StockSEC:0001140361-26-032818:0
73,313 shares0Common StockSEC:0001140361-26-031473:0
61,963 shares0Common StockSEC:0001140361-26-005408:0
407,166 shares0Common StockSEC:0001140361-25-029144:0
4 of 4 declarations
